Recent Updates
Recently added Catalysts
LLY

Lilly to Participate in UBS Global Healthcare Conference Eli Lilly and Company (NYSE:LLY) will attend the UBS Global Healthcare Conference on Tuesday, May 21, 2019. Christi Shaw, president of Lilly...

Key Takeaway: INDIANAPOLIS , May 16, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will attend the UBS Global Healthcare Conference on Tuesday, May 21, 2019 . Christi Shaw , president of Lilly Bio-Medicines, will participate in a fireside chat at 9:30 a.m., Eastern Time. A live audi

Conference Participation Details

UBS Global Healthcare Conference
Date: November 11, 2025
Time: 8:45 a.m. ET
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Full Press Release Details

INDIANAPOLIS , May 16, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will attend the UBS Global Healthcare Conference on Tuesday, May 21, 2019 . Christi Shaw , president of Lilly Bio-Medicines, will participate in a fireside chat at 9:30 a.m., Eastern Time.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at http://investor.lilly.com/events.cfm . A replay of the presentation will be available on this same website for approximately 90 days.
About Eli Lilly and Company Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels . F-LLY
Refer to: Mark Taylor; [email protected] ; (317) 276-5795 (Media)
Kevin Hern; [email protected] ; (317) 277-1838 (Investors)
SOURCE Eli Lilly and Company

Related Links

21 %

Last updated: May 16, 2019